Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes. International Journal of Biomedical Research, [S. l.], v. 7, n. 5, p. 276–282, 2016. DOI: 10.7439/ijbr.v7i5.3273. Disponível em: https://ssjournals.co.in/index.php/ijbr/article/view/3273. Acesso em: 22 apr. 2026.